TECHNICAL BUY OF THIS PHARMA PLAYER- Dishman Carbogen Amcis Ltd:

Dishman Carbogen Amcis Ltd is a fully integrated CRAMS player working with global pharmaceutical innovators, has a global presence with development and manufacturing facilities across Europe, India, and China. We provide end-to-end, integrated, high-value, niche CRAMS offering, right from process research and development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies. In the weekly chart, this stock breaks out above Rs.213 forming an Inverted Head and Shoulder. Buy at CMP-237 with target-400 within one year maintaining the stop loss 200